THE INSTITUTE FOR CANCER RESEARCH
PHILADELPHIA, Pennsylvania
Total Received
$251.9M
Total Awards
113
State
Pennsylvania
Last Updated
Mar 20, 2026
Yearly Funding Trend
$194.0M24
$53.2M25
$4.7M26
Top 50 Awards to THE INSTITUTE FOR CANCER RESEARCH
Largest individual federal awards on record for this recipient, ranked by obligated amount. Data through March 20, 2026.
| Award | Awarding Agency | Program | Place | FY | Obligation |
|---|---|---|---|---|---|
ASST_NON_P30CA006927_075 COMPREHENSIVE CANCER CENTER PROGRAM AT FOX CHASE - IN NOVEMBER 2021, JONATHAN CHERNOFF, MD, PHD, WAS APPOINTED DIRECTOR OF FCCC, AND TO A NEW POSITION AS SENIOR ASSOCIATE DEAN FOR… | Department of Health and Human Services National Institutes of Health | 93.397 CANCER CENTERS SUPPORT GRANTS | PA-90 | 2024 | $70,430,265 |
ASST_NON_P01AI102853_075 MOLECULAR BASIS OF ΓΔ T LINEAGE SPECIFICATION - PROJECT SUMMARY/ABSTRACT DESPITE THE GROWING APPRECIATION FOR THE CRITICAL ROLE PLAYED BY ΓΔ T CELLS IN HOST DEFENSE AND IMMUNOPATH… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | PA-90 | 2025 | $21,616,755 |
ASST_NON_R01AI135025_075 MECHANISM, FUNCTION, AND EXPLOITATION OF INFLUENZA A VIRUS-ACTIVATED CELL DEATH - PROJECT SUMMARY/ABSTRACT INFLUENZA A VIRUS (IAV) TRIGGERS THE DEATH OF MOST CELL TYPES IN WHICH I… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | PA-90 | 2024 | $6,796,872 |
ASST_NON_R35GM122517_075 STRUCTURAL BIOINFORMATICS OF PROTEINS AND PROTEIN COMPLEXES AND APPLICATIONS TO CANCER BIOLOGY - PROJECT SUMMARY/ABSTRACT STRUCTURAL BIOLOGY HAS A FUNDAMENTAL ROLE TO PLAY IN THE… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | PA-90 | 2024 | $5,529,680 |
ASST_NON_U54CA272686_075 CANCER PREVENTION-INTERCEPTION TARGETED AGENT DISCOVERY PROGRAM AT FOX CHASE CANCER CENTER - PROJECT SUMMARY - OVERALL HEREDITABLE CANCER-PREDISPOSING MUTATIONS ARE ESTIMATED TO B… | Department of Health and Human Services National Institutes of Health | 93.399 CANCER CONTROL | PHILADELPHIA, PA-02 | 2024 | $5,240,348 |
ASST_NON_R35GM119560_075 MOLECULAR MECHANISMS UNDERLYING ADAPTOR-MEDIATED INTEGRIN SIGNALING IN A SPECIES-SPECIFIC MANNER - PROJECT SUMMARY/ABSTRACT MY LABORATORY IS INTERESTED IN UNDERSTANDING THE MOLEC… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | PHILADELPHIA, PA-02 | 2024 | $4,932,440 |
ASST_NON_R37AI110985_075 REGULATION OF HEMATOPOIESIS BY RIBOSOMAL PROTEIN PARALOGS - RIBOSOMAL PROTEINS (RP) PLAY CRUCIAL REGULATORY ROLES IN DEVELOPMENT AND DISEASE, BUT THE WAY THEY DO SO REMAINS UNCLEA… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | PHILADELPHIA, PA-02 | 2024 | $4,179,674 |
ASST_NON_R01MD012621_075 IMMIGRANT ENCLAVES: CONFERRING HEALTH ADVANTAGES OR CREATING HEALTH DISPARITIES IN CHINESE IMMIGRANTS? - PROJECT SUMMARY THE US HAS THE WORLD'S LARGEST IMMIGRANT POPULATION. AS MO… | Department of Health and Human Services National Institutes of Health | 93.307 MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH | PA-90 | 2024 | $3,865,016 |
ASST_NON_R01AI144400_075 TARGETING RIPK3 IN FLU-ASSOCIATED LUNG INJURY - PROJECT SUMMARY/ABSTRACT SEASONAL INFLUENZA A VIRUS (IAV) INFECTIONS ACCOUNT FOR OVER 700,000 HOSPITALIZATIONS AND 50,000 ANNUAL DE… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | PA-90 | 2026 | $3,620,917 |
ASST_NON_R01CA248655_075 EVIDENCE-BASED APPROACH TO EMPOWER ASIAN AMERICAN WOMEN IN CERVICAL CANCER SCREENING - PROJECT SUMMARY THE INTRODUCTION OF THE PAP TEST HAS LED TO SIGNIFICANT REDUCTIONS IN CERVIC… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | PHILADELPHIA, PA-02 | 2024 | $3,517,924 |
ASST_NON_R01CA238061_075 INVESTIGATING GENETIC ANCESTRY INFLUENCES ON ORAL CAVITY AND LARYNGEAL CANCER SURVIVAL DISPARITIES - PROJECT SUMMARY/ABSTRACT SURVIVAL FROM HEAD AND NECK SQUAMOUS CELL CARCINOMA (… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | PA-90 | 2025 | $3,354,560 |
ASST_NON_R01MD013347_075 EXTENDING A CARIBBEAN BASED COHORT TO PROMOTE US-CARIBBEAN COMPARISONS TO FACILITATE RESEARCH ADDRESSING BLACK HEALTH DISPARITIES - PROJECT SUMMARY/ABSTRACT FIFTY PERCENT OF NON-H… | Department of Health and Human Services National Institutes of Health | 93.307 MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH | PA-90 | 2024 | $3,333,375 |
ASST_NON_R01CA194263_075 UNDERSTANDING PSYCHOSOCIAL AND IMMUNOLOGIC RESPONSES IN INDOLENT LYMPHOPROLIFERATIVE DISORDERS - DESCRIPTION (PROVIDED BY APPLICANT): IN 2015, ABOUT 71,850 CASES OF NON-HODGK… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | PHILADELPHIA, PA-02 | 2024 | $3,192,741 |
ASST_NON_R01CA236391_075 NOVEL ROLE OF THPOK IN MAMMARY CARCINOMA - PROJECT SUMMARY/ABSTRACT OVERVIEW: THERE IS AN URGENT NEED TO UNDERSTAND THE MOLECULAR BASIS OF HER2+ BREAST CANCER, GIVEN THAT THE MAJO… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | PA-90 | 2025 | $3,146,529 |
ASST_NON_R01CA214799_075 COMPENSATORY MECHANISMS THAT PROMOTE HOMOLOGOUS RECOMBINATION IN BRCA1 MUTANT CANCERS - PROJECT SUMMARY A FREQUENT MODE OF THERAPY RESISTANCE IS THROUGH THE RESTORATION OF HOMOLOG… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | PA-90 | 2024 | $3,047,681 |
ASST_NON_R01CA222124_075 ADDRESSING SEXUAL CONCERNS IN BREAST CANCER SURVIVORS: RCT OF A NOVEL COUPLE-BASED INTERVENTION - PROJECT SUMMARY/ABSTRACT THE MAJORITY OF BREAST CANCER SURVIVORS EXPERIENCE SEXUA… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | PA-90 | 2025 | $3,032,611 |
ASST_NON_R01CA269975_075 SMALL-MOLECULE EXPLOITATION OF ZBP1-DRIVEN NUCLEAR NECROPTOSIS FOR CANCER IMMUNOTHERAPY - PROJECT SUMMARY/ABSTRACT. IMMUNE CHECKPOINT BLOCKADE (ICB) AND OTHER IMMUNOTHERAPIES HAVE… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | PHILADELPHIA, PA-02 | 2024 | $2,922,093 |
ASST_NON_DP2CA258224_075 NEW TOOLS FOR UNDERSTANDING METASTASIS THROUGH TISSUE RESIDENT CELLS: ENABLING AN EXTENSIVE MEDICINE STRATEGY FOR METASTATIC DISEASE - PROJECT SUMMARY CANCER REMAINS A MENACE BECA… | Department of Health and Human Services National Institutes of Health | 93.310 TRANS-NIH RESEARCH SUPPORT | PA-90 | 2025 | $2,805,000 |
ASST_NON_R01MD017675_075 REDUCING URBAN CERVICAL CANCER DISPARITIES USING A TAILORED MHEALTH INTERVENTION TO ENHANCE COLPOSCOPY ATTENDANCE - PROJECT SUMMARY/ABSTRACT CERVICAL CANCER IS ONE OF THE MOST PRE… | Department of Health and Human Services National Institutes of Health | 93.307 MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH | PHILADELPHIA, PA-02 | 2024 | $2,707,916 |
ASST_NON_R01MD018511_075 NEIGHBORHOOD, SOCIAL CONNECTEDNESS, AND ALLOSTATIC LOAD - MODIFIED PROJECT SUMMARY/ABSTRACT SECTION THE ASIAN AMERICAN POPULATION IS ONE OF THE FASTEST-GROWING GROUPS IN THE UNITE… | Department of Health and Human Services National Institutes of Health | 93.307 MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH | PHILADELPHIA, PA-02 | 2024 | $2,592,747 |
ASST_NON_R01CA269660_075 PANCREATIC CANCER-ASSOCIATED FIBROBLASTS: FUNCTION, DETECTION, AND REGULATION - PROJECT SUMMARY/ABSTRACT PANCREATIC CANCER INDUCES A FIBROUS MICROENVIRONMENT, DESMOPLASIA, WHICH S… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | PHILADELPHIA, PA-02 | 2024 | $2,559,695 |
ASST_NON_R01AI171568_075 ROLE OF ZBP1 IN PATHOGENESIS OF SALMONELLA BIOFILMS - PROJECT SUMMARY INFECTIONS WITH ENTERIC PATHOGENS SUCH AS SALMONELLA, CAMPYLOBACTER, SHIGELLA, OR YERSINIA ARE LEADING CAUSES… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | PHILADELPHIA, PA-02 | 2024 | $2,527,208 |
ASST_NON_R01CA217161_075 LUNG CANCER IN NEVER-SMOKERS: ROLE OF ESTROGEN AND ITS METABOLITES - PROJECT SUMMARY LUNG CANCER AMONG NEVER-SMOKERS IS CURRENTLY ONE OF THE TOP TEN CAUSES OF CANCER MORTALITY WOR… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | PHILADELPHIA, PA-02 | 2024 | $2,477,914 |
ASST_NON_R01CA227184_075 TARGETING THE RAC1 SIGNALING PATHWAY IN MALIGNANT MELANOMA - PROJECT SUMMARY/ABSTRACT RECENT ADVANCES IN SEQUENCING TECHNOLOGY HAVE HELPED UNCOVER A VARIETY OF NEW DRIVER MUTATION… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | PA-90 | 2025 | $2,459,248 |
ASST_NON_R01GM141513_075 DESIGNING SELECTIVE KINASE INHIBITORS VIA DEEP LEARNING - PROJECT SUMMARY/ABSTRACT MODERN CANCER BIOLOGY LEANS HEAVILY ON KINASE INHIBITORS AS A MEANS TO PROBE THE CONSEQUENCES O… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | PA-90 | 2024 | $2,379,505 |
ASST_NON_R35GM144131_075 DECIPHERING NETWORKS CONTROLLING DNA AMPLIFICATION - PROJECT SUMMARY DNA AMPLIFICATION IS ASSOCIATED WITH PATHOLOGICAL STATES SUCH AS NEUROLOGICAL DISORDERS, CARDIAC DISEASE AND C… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | PHILADELPHIA, PA-02 | 2024 | $2,337,500 |
ASST_NON_R01CA262466_075 ASSESSING DNA POLYMERASE THETA AS A THERAPEUTIC TARGET IN BRCA1 MUTANT CANCER - PROJECT SUMMARY GENETIC DISRUPTION OF DNA POLYMERASE THETA (POLΘ) ACTIVITY HAS BEEN SHOWN TO EFFECT… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | PHILADELPHIA, PA-02 | 2024 | $2,320,147 |
ASST_NON_R01CA251674_075 ANALYSIS AND THERAPEUTIC TARGETING OF THE LINEAR-UBIQUITINATION PATHWAY IN HODGKIN LYMPHOMA - PROJECT SUMMARY HODGKIN LYMPHOMA (HL) IS THE MOST COMMON (6,000 TO 7,000 NEW CASES PE… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | PHILADELPHIA, PA-02 | 2024 | $2,108,871 |
ASST_NON_R01CA245871_075 MTAP, 5'-DEOXY-5'-METHYLTHIOADENOSINE, AND THE DYSREGULATION OF SYMMETRIC DIMETHYLARGININE IN CANCER - PROJECT SUMMARY METHYLTHIOADENOSINE PHOSPHORYLASE (MTAP) IS A KEY ENZYME IN… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | PHILADELPHIA, PA-02 | 2024 | $2,100,315 |
ASST_NON_R01CA212662_075 EXPLOITING VULNERABILITIES IN GIST USING NOVEL COMBINATION THERAPIES - GASTROINTESTINAL STROMAL TUMOR (GIST) TREATED WITH TARGETED THERAPIES SUCH AS IMATINIB MESYLATE (IM), SUNITI… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | PHILADELPHIA, PA-02 | 2024 | $2,098,806 |
ASST_NON_R01CA283396_075 DIVERGENT FUNCTIONS OF ERK SUBSTRATE BINDING DOMAINS IN PATHOGENESIS OF MYELOPROLIFERATIVE NEOPLASMS - PROJECT SUMMARY/ABSTRACT THE RAS/MAPK PATHWAY IS ACTIVATED IN 85% OF HUMAN C… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | PHILADELPHIA, PA-02 | 2024 | $2,085,781 |
ASST_NON_R01CA262551_075 FOLIC ACID SUPPLEMENTATION AND COLITIS-ASSOCIATED COLON CARCINOGENESIS - PROJECT SUMMARY/ABSTRACT PATIENTS WITH ULCERATIVE COLITIS, A FORM OF INFLAMMATORY BOWEL DISEASE, FACE AN… | Department of Health and Human Services National Institutes of Health | 93.393 CANCER CAUSE AND PREVENTION RESEARCH | PHILADELPHIA, PA-02 | 2024 | $2,082,906 |
CONT_AWD_75N91022F00001_7529_75N91019D00022_7529 BASE TITLE: PREVENT PRECLINICAL DRUG DEVELOPMENT PROGRAM: PRECLINICAL EFFICACY AND INTERMEDIATE ENDPOINT BIOMAKERS TASK ORDER TITLE: VACCINES AGAINST FUSOBACTERIUM FOR FAP-AND L… | Department of Health and Human Services National Institutes of Health | — | PHILADELPHIA, PA-02 | 2024 | $2,051,148 |
ASST_NON_R01CA259188_075 INVESTIGATING THE IL-1R PATHWAY IN ANAPLASTIC LARGE CELL LYMPHOMA FOR TARGETED THERAPY - PROJECT SUMMARY ANAPLASTIC LARGE CELL LYMPHOMA (ALCL) COMPRISES A COLLECTION OF MATURE T-C… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | PHILADELPHIA, PA-02 | 2024 | $2,022,453 |
ASST_NON_U01CA260369_075 OPTIMIZATION OF URINARY DNA DEEP SEQUENCING TESTS TO ENHANCE CLINICAL STAGING OF BLADDER CANCER PATIENTS - PROJECT SUMMARY/ABSTRACT MUSCLE-INVASIVE BLADDER CANCER (MIBC) IS OPTIM… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | PHILADELPHIA, PA-02 | 2024 | $2,009,718 |
ASST_NON_HT94252510908_097 PEMBROLIZUMAB MAINTENANCE AFTER ENFORTUMAB VEDOTIN/PEMBROLIZUMAB INDUCTION IN FRONT-LINE METASTATIC UROTHELIAL CARCINOMA. | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | PHILADELPHIA, PA-02 | 2025 | $1,959,353 |
ASST_NON_R01GM135293_075 DISSECTING BRCA1-PALB2 ACTIVITY IN DNA REPAIR AND DEVELOPMENT - PROJECT SUMMARY THE BRCA1 AND PALB2 PROTEINS DIRECTLY HETERODIMERIZE THROUGH THEIR RESPECTIVE COILED-COIL (CC) DOMA… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | PA-90 | 2025 | $1,881,854 |
ASST_NON_R01HL150190_075 THE ROLE OF MICROHOMOLOGY-MEDIATED END JOINING IN FANCONI ANEMIA PATHOGENESIS - PROJECT SUMMARY CHILDREN WITH FANCONI ANEMIA (FA) DEMONSTRATE DEVELOPMENTAL DISORDERS THAT INCLUDE… | Department of Health and Human Services National Institutes of Health | 93.837 CARDIOVASCULAR DISEASES RESEARCH | PA-90 | 2024 | $1,856,590 |
ASST_NON_R01AI130022_075 HEPATITIS B VIRUS CCCDNA - PROJECT SUMMARY HEPATITIS B VIRUS CHRONICALLY INFECTS APPROXIMATELY 300 MILLION PEOPLE WORLDWIDE. ALL ARE AT SIGNIFICANTLY INCREASED RISK OF DEVELOPING… | Department of Health and Human Services National Institutes of Health | 93.855 ALLERGY AND INFECTIOUS DISEASES RESEARCH | PHILADELPHIA, PA-02 | 2024 | $1,830,000 |
ASST_NON_R01CA281212_075 ELUCIDATING THE CRITICAL ROLE OF WEE1 IN GIST - PROJECT SUMMARY MANAGEMENT OF GASTROINTESTINAL STROMAL TUMOR (GIST) TREATMENT HAS BEEN REVOLUTIONIZED BY THE IDENTIFICATION OF ACTI… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | PHILADELPHIA, PA-02 | 2024 | $1,698,698 |
ASST_NON_R01CA289703_075 HEPATIC TISSUE INTEGRITY AND CLONAL FITNESS: KEY FACTORS IN CONTROLLING Β-CATENIN INDUCED ONCOGENESIS - PROJECT SUMMARY GIVEN THE IMPORTANCE OF MUTATIONS IN ONCOGENES AND TUMOR SU… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | PHILADELPHIA, PA-02 | 2024 | $1,657,394 |
ASST_NON_R35GM150538_075 TELOMERASE RNP PRISONBREAKS FROM PHASE-SEPARATED NUCLEAR BODY - PROJECT SUMMARY OVERVIEW: THE RIBONUCLEOPROTEIN ENZYME TELOMERASE MAINTAINS TELOMERE LENGTH HOMEOSTASIS – A SHARED… | Department of Health and Human Services National Institutes of Health | 93.859 BIOMEDICAL RESEARCH AND RESEARCH TRAINING | PA-90 | 2024 | $1,649,252 |
ASST_NON_R01MD018146_075 EXAMINING THE RELATIONSHIP BETWEEN RESIDENTIAL HISTORY AT MIDLIFE AND PROSTATE CANCER OUTCOMES - PROSTATE CANCER (PCA) IS ONE OF A FEW CANCERS WITH MORE THAN DOUBLE THE MORTALITY… | Department of Health and Human Services National Institutes of Health | 93.307 MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH | PA-90 | 2024 | $1,561,820 |
ASST_NON_R01CA282766_075 INTERROGATING MRCK PROTEIN KINASES IN OVARIAN CANCER - THE MAJORITY OF RECURRENT OVARIAN CANCERS SPREAD TO THE PERITONEAL CAVITY IN THE FORM OF ASCITES, WHERE TUMOR CELLS GROW AS… | Department of Health and Human Services National Institutes of Health | 93.395 CANCER TREATMENT RESEARCH | PHILADELPHIA, PA-02 | 2024 | $1,546,959 |
ASST_NON_W81XWH2110487_097 OVERCOMING RESISTANCE TO EGFR INHIBITORS IN ADVANCED HEAD AND NECK CANCERS EXTEND THE PERIOD OF PERFORMANCE 1. PER SECTION 711 OF THE NATIONAL DEFENSE AUTHORIZATION ACT (NDAA) 201… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | PHILADELPHIA, PA-02 | 2025 | $1,402,500 |
ASST_NON_W81XWH2210368_097 IMPACT OF SOCIAL DETERMINANTS OF HEALTH ON QUALITY OF LIFE AND TREATMENT-RELATED DECISION-MAKING IN ADVANCED PROSTATE CANCER EXTEND THE PERIOD OF PERFORMANCE, REMOVE FUNDING RESTR… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | PHILADELPHIA, PA-02 | 2025 | $1,402,500 |
ASST_NON_W81XWH2210790_097 DELINEATING THE ROLE OF THE ACETYL-COA PATHWAY IN THE RESISTANCE TO ANTI-ANDROGEN THERAPY EXTEND THE PERIOD OF PERFORMANCE 1. PER SECTION 711 OF THE NATIONAL DEFENSE AUTHORIZATION… | Department of Defense Defense Health Agency | 12.420 MILITARY MEDICAL RESEARCH AND DEVELOPMENT | PHILADELPHIA, PA-02 | 2025 | $1,368,836 |
ASST_NON_R37CA283552_075 TARGETING DHX9 TO TRIGGER VIRAL MIMICRY AND IMMUNOTHERAPY RESPONSIVENESS IN SMALL CELL LUNG CANCER (SCLC) - PROJECT SUMMARY / ABSTRACT DESPITE THE IMPRESSIVE CLINICAL SUCCESS OF I… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | PHILADELPHIA, PA-02 | 2024 | $1,299,358 |
ASST_NON_R01CA289629_075 TARGETING ANOCTAMIN 6 TO DISRUPT TROGOCYTOSIS OF CANCER-ASSOCIATED FIBROBLASTS - PROJECT SUMMARY THE FIBROBLASTIC STROMA COMPRISES MOST OF PANCREATIC ADENOCARCINOMA MASS AND IS RE… | Department of Health and Human Services National Institutes of Health | 93.396 CANCER BIOLOGY RESEARCH | PHILADELPHIA, PA-02 | 2025 | $1,285,510 |
ASST_NON_UG3HL170034_075 ASIAN AMERICAN COMMUNITY COHORT AND EQUITY STUDY (ACCESS) - PROJECT SUMMARY BETWEEN 2000 AND 2020, ASIAN AMERICANS WERE THE FASTEST GROWING RACIAL GROUP IN THE US, INCREASING FROM… | Department of Health and Human Services National Institutes of Health | 93.172 HUMAN GENOME RESEARCH | PA-90 | 2024 | $1,255,726 |
Top 50 awards shown, ranked by obligated amount. Dates reflect performance period; last-modified dates match USAspending.gov. Complete listings include all transaction history going back to FY2024.
Federal Programs (CFDA)
View All→12345678910
93.397 — CANCER CENTERS SUPPORT GRANTS$70.4M
93.855 — ALLERGY AND INFECTIOUS DISEASES RESEARCH$43.3M
93.396 — CANCER BIOLOGY RESEARCH$23.1M
93.395 — CANCER TREATMENT RESEARCH$21.7M
93.393 — CANCER CAUSE AND PREVENTION RESEARCH$20.9M
93.859 — BIOMEDICAL RESEARCH AND RESEARCH TRAINING$20.8M
12.420 — MILITARY MEDICAL RESEARCH AND DEVELOPMENT$15.6M
93.307 — MINORITY HEALTH AND HEALTH DISPARITIES RESEARCH$14.7M
93.399 — CANCER CONTROL$5.2M
93.310 — TRANS-NIH RESEARCH SUPPORT$2.8M
Source: USAspending.gov · All Recipients · Pennsylvania